Similar effects on monocyte populations have been demonstrated in DMF treated MS patients, with peripheral monocytes showing reduced levels of mir-155, a micro-RNA associated with major pro-inflammatory effect [125], while in vitro treated human monocytes showed suppressed TNFα, IL-6 and IL-10 responses to a pro-inflammatory stimulus [125]. The gene discussed is IL10; the disease is myeloid sarcoma.